Hepatitis C Drug Market

Published on 2023-01-10

Report Code: 1297

170 -350 pages

Hepatitis C Drug Market: By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032

Buy Now

Add to cart

Table Of Content

1 Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Hepatitis C Drug Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot

2 Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation

3 Market Characteristics
3.1. Market Definition
3.2. Hepatitis C Drug Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4 Hepatitis C Drug Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5 Macroeconomic Indicators

6 Recent Developments

7 Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends

8 Risk Analysis

9 Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological

10 Hepatitis C Drug Market
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11 Hepatitis C Drug Market Size & Forecast 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product
11.3.1.1. NS5A Inhibitor (Protease Inhibitor)
11.3.1.1.1 By Value (USD Million) 2022-2032F
11.3.1.1.2 Market Share (%) 2022-2032F
11.3.1.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Fixed- dose Combination
11.3.1.2.1 By Value (USD Million) 2022-2032F
11.3.1.2.2 Market Share (%) 2022-2032F
11.3.1.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Others
11.3.1.3.1 By Value (USD Million) 2022-2032F
11.3.1.3.2 Market Share (%) 2022-2032F
11.3.1.3.3 Y-o-Y Growth (%) 2022-2032F
11.3.2. By Disease Type
11.3.2.1. Acute Hepatitis C
11.3.2.1.1 By Value (USD Million) 2022-2032F
11.3.2.1.2 Market Share (%) 2022-2032F
11.3.2.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Chronic Hepatitis C
11.3.2.2.1 By Value (USD Million) 2022-2032F
11.3.2.2.2 Market Share (%) 2022-2032F
11.3.2.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.3. By Distribution Channel
11.3.3.1. Hospital Pharmacies
11.3.3.1.1 By Value (USD Million) 2022-2032F
11.3.3.1.2 Market Share (%) 2022-2032F
11.3.3.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Retail Pharmacies
11.3.3.2.1 By Value (USD Million) 2022-2032F
11.3.3.2.2 Market Share (%) 2022-2032F
11.3.3.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Online Pharmacies
11.3.3.3.1 By Value (USD Million) 2022-2032F
11.3.3.3.2 Market Share (%) 2022-2032F
11.3.3.3.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1 By Value (USD Million) 2022-2032F
11.3.3.4.2 Market Share (%) 2022-2032F
11.3.3.4.3 Y-o-Y Growth (%) 2022-2032F

12 North America Hepatitis C Drug Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2. By Disease Type
12.3.3. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada

13 Europe Hepatitis C Drug Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2. By Disease Type
13.3.3. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14 Asia Hepatitis C Drug Market Size & Forecast 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2. By Disease Type
14.3.3. By Distribution channel
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC

15 Middle East and Africa Hepatitis C Drug Market Size & Forecast 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2. By Disease Type
15.3.3. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa

16 Latin America Hepatitis C Drug Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2. By Disease Type
16.3.3. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America

17 Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders

18 Company Profiles
18.1. AbbVie Inc
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Gilead Sciences Inc.
18.3. Janssen Pharmaceuticals Inc
18.4. Kennilworth
18.5. Bristol-Myers Squibb Company
18.6. Merck Sharp & Dohme Corp
18.7. F. Hoffmann-La Roche Ltd
18.8. Zydus Cadilla
18.9. LAURUS Labs
18.10. Hetero Healthcare Ltd
18.11. Cipla Inc
18.12. Basel GlaxoSmithKline
18.13. Vertex Pharmaceuticals
18.14. Other prominent players